|
No, T-cell depletion is the type of transplant that they do. They remove the donor's t-cells so they don't attack you in some way. However, they can add them in and sometimes do if you need them. The transplant is more of a syringe-instead of a bag of blood. Even more anti-climatic.
Campath is the trial drug of NIH that is in comparison to ATG.
Are you sure it wasn't Cyclophosphamide instead of Campath? They all have different preparatory regimens...
__________________
Marian , Dx 12/25/09 w/ hypoplastic myelodysplasia and 10% PNH clone. Dx changed to SAA in 1/10, treated w/ unsuccessful horse ATG and cyclosporine. Dx of unclassified MDS or acquired bone marrow failure, PNH clone 39% (after ATG). Due for BMT in Sept or Oct 2010.
|